Navigation Links
Consumer Group Responds to Governor Schwarzenegger's Incorrect Claims About the Impact of Medical Malpractice Caps
Date:10/29/2009

SANTA MONICA, Calif., Oct. 29 /PRNewswire-USNewswire/ -- Consumer Watchdog sent the following letter to Congressional leaders today in response to a letter sent by California Governor Arnold Schwarzenegger in which he incorrectly cited California's draconian limits on the legal rights of injured patients as a successful cost containment tool. Consumer Watchdog is a nonpartisan nonprofit with offices in California and Washington, D.C. The Governor's October 27, 2009 letter is available at www.gov.ca.gov/archive/press-releases/.

October 29, 2009

The Honorable Harry Reid

Majority Leader

United States Senate

Washington, DC 20510

The Honorable Nancy Pelosi

Speaker of the House

U.S. House of Representatives

Washington, DC 20515

The Honorable Mitch McConnell

Minority Leader

United States Senate

Washington, DC 20510

The Honorable John A. Boehner

Minority Leader

U.S. House of Representatives

Washington, DC 20515

Dear Senator Reid, Senator McConnell, Madam Speaker and Mr. Boehner,

Tuesday, California Governor Arnold Schwarzenegger wrote you regarding his views on health care reform. While Consumer Watchdog has detailed its views on comprehensive federal health reform many times over the past year, we write today in response to a particular element of the debate addressed by Governor Schwarzenegger, in which he incorrectly cited California's draconian limits on the legal rights of injured patients as a successful cost containment tool.

The plight of injured patients and families subject to unjust legal restriction in California has been well documented. Jury-ordered compensation been slashed by a one-size-fits-all damages cap unadjusted for three decades. Too many children, seniors
'/>"/>

SOURCE Consumer Watchdog
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA and WebMD Expand Consumer Health Information Partnership
2. SmartOps and Wyeth Consumer to Present at SAP(R) World Tour 2009
3. SAMHSA Honors The Soloist, Greys Anatomy, United States Of Tara, and Mental Health Consumer Leaders at The Star-Studded 2009 Voice Awards
4. Healthy Advice Networks Now Able to Track Consumer Purchase Behavior
5. Consumers Compare Virginia HMOs on Quality and Satisfaction - Scores Improve in Newest Report
6. Emerging Consensus to Create a Health Internet With Broad Consumer Engagement
7. Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives
8. The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company
9. Long-Term Care Consumer Voices Strengthened
10. Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials Hyperbolic PSA Campaign
11. Eleven Health & Consumer Groups Urge Federal Court to Reject Tobacco Companies Lawsuit Against FDA Tobacco Regulation Law
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... ... , ... Illinois Health & Science (IHS) has completed the purchase of IBA ... of IBAM NA’s cyclotron sites and research and development facilities. , “We ... well as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... with accountability for overall performance of the company’s Medicare and Federal Employee Programs ... Cambia’s strategy to deliver better health for members. In this role, Scott is ...
(Date:8/3/2015)... (PRWEB) , ... August 03, ... ... (EMSI), a leading provider of medical information, risk management and investigative services, ... evolution and direction toward focused, expert information solutions that improve business outcomes ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... Institute of Medical Sciences (KIMS), a leading hospital here, ... accreditation that will// help it attract patients from abroad. ... the Australian Council for Health Care Standards International (ACHSI), ... extensive, week-long survey of KIMS facilities. KIMS has become ...
... from chronic asthma do not get proper treatment and ... ,Specialists at the Johns Hopkins Children’s Center and elsewhere ... the researchers say, because preventive therapy failure leads to ... strikes and to more complications and increased risk of ...
... tiny heating device that can be inserted inside the lungs ... or nose can help treat asthma, researchers conducting its// trial ... system in which the airways constrict making it hard to ... ,Though asthma can't be cured, it can be managed with ...
... senior and well-known scientist of America’s premier medical agency ... criminal conflict of interests.// ,Dr Trey Sutherland ... drug company as consulting fees as well as providing ... is said to have received $285,000 in payment for ...
... the anti-craving drug, Naltrexone may lessen cessation-related weight gain ... quit smoking appear //to benefit more than men. As ... on gender differences in nicotine addiction and in treatment. ... of the University of Chicago have added a drug ...
... hair-growth drug finasteride, taken by millions of balding men, ... test,// the standard screening test for prostate cancer, a ... men ranging in age from 40 to 60 years ... The Lancet and is scheduled to be published after ...
Cached Medicine News:Health News:Medication Not Available On Time To Inner-city Children 2Health News:Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening 2
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... OAKS, Calif. , July 30, 2015  Amgen (NASDAQ: ... Hassan , partner and managing director of Warburg Pincus LLC, ... are pleased to welcome Fred Hassan and the ... the Amgen Board," said Robert A. Bradway , chairman ... and commitment to innovation will serve Amgen well." ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Corporation (Nasdaq: DNDN ) today reported results for ... quarter ended September 30, 2010 was $20.2 million compared to ... the nine months ended September 30, 2010 was $23.1 million ... 2009.   Revenue from sales of PROVENGE® (sipuleucel-T) ...
... EMERYVILLE, Calif., Nov. 3, 2010 Onyx Pharmaceuticals, ... results for the third quarter 2010. Onyx reported non-GAAP net ... the third quarter 2010 compared to non-GAAP net income of ... period in 2009. Non-GAAP net income excludes, among other items, ...
Cached Medicine Technology:Dendreon Reports Third Quarter 2010 Financial Results 2Dendreon Reports Third Quarter 2010 Financial Results 3Dendreon Reports Third Quarter 2010 Financial Results 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 2Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 3Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 5Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 6Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 7Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 8Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 9Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 10
... is synthesized by the parathyroid glands ... decreased extracellular calcium concentrations. PTH prevents ... decreasing calcium excretion by the kidney. ... PTH is rapidly degraded into 4 ...
... is produced in the adrenal cortex and, ... DHEA serves as a precursor in testosterone ... androgenic activity, estimated at ~10% that of ... and in adult women, DHEA is an ...
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
... is a 32 kDa glycoprotein secreted by ... gland [1]. The structure of human TSH ... and placental gonadotropins, consisting of an a-subunit ... hormones and a unique beta-subunit, which confers ...
Medicine Products: